How to Use a Living HTA Approach to Demonstrate Value in Real-Time (2024)

Home

How to Use a Living HTA Approach to Demonstrate Value in Real-Time (1)

Perspectives

How to Use a Living HTA Approach to Demonstrate Value in Real-Time (2)

How to Use a Living HTA Approach to Demonstrate Value in Real-Time

How to Use a Living HTA Approach to Demonstrate Value in Real-Time

How to Use a Living HTA Approach to Demonstrate Value in Real-Time (3)
Cytel

When submitting systematic literature reviews to a Health Technology Assessment authority, high volumes of research output have led industry bodies like PRISMA and Cochrane to call for a paradigm shift towards “Living HTA” models that organize and update evidence in a more continuous manner. In the past decade such concepts have been introduced for both SLRs and network meta-analyses, but the industry has been hesitant to take up this approach in practice. A new Cytel whitepaper aims to provide a blueprint for those seeking to access evidence quickly, and integrate the most up-to-date science into research, such as SLRs.

What is a Living HTA Model?

The idea of a Living HTA Model is probably familiar to many who conduct SLRs and NMAs, and need to constantly update their model as data accrues. These models anticipate the evolution of knowledge in a fast-paced industry. According to the European Commission’s Next Generation Health Technology Assessment, such models should ideally be able to handle both the updating of newly published evidence, as well as account for missing data and sensitivity analysis. As a result, they should also be useful for ensuring transparent clinical and public health decision-making in light of such new evidence.

While it is one thing for the European Commission or World Health Organization to plan for the grand synchronization of evidence, how can the average organization ensure that their HTA submissions live up to this ideal? Although seemingly an ambitious task, new digital tools and collaboration in the aftermath of COVID-19 allow this dictum to be a realizable goal.

A recent client of Cytel’s for example, was asked to provide an SLR within a 2-month window, in a therapeutic area where 50 new abstracts are published on a monthly basis. Thankfully, they were able to utilize an existing Cytel library (The PubTracker) of research abstracts curated by disease, and constantly updated by Cytel experts. The notion of a curated disease library is essential for any living model, enabling sponsors to access all relevant evidence in minutes.

In addition to updating the content of such a curated library, Cytel’s data scientists have ensured that those using The PubTracker can quickly search by interventions, indications and study types, as well as the elements constituting a global value dossier. Since the library is curated by experts, they can also be customized depending on the needs of a specific client’s SLR. One client, for example, requested a customization that led to over 450 RWE publications added for the specific disease of interest.

What is LiveSLR®?

LiveSLR® is a digital tool that works with PubTracker to ensure SLRs are quickly generated that maintain the standards set by HTA authorities. These NICE-grade SLRs are quickly assembled for sponsors, consolidating information through what is essentially a Living SLR model. Sponsors, though, are no longer responsible for building their own live models. They can rely on the services of the PubTracker curators, when they subscribe to this digital tool to create SLR reports.

Subscribe to our newsletter

Related Articles

Subpopulations in Clinical Trial Design: Thinking Through Hypothesis Testing

Subpopulations are often of key interest in clinical trials. For example, an investigational drug may be targeted to have efficacy on a particular subpopulation of patients who test positive for a specific biomarker. That drug may also be thought to have some degree of benefit, though lesser, on the opposite subpopulation—those who test negative for […]

Read more

Behind the Oncology Research : An Interview Between Robert Szulkin and Jana de Boniface

Welcome to our interview with Dr. Jana de Boniface, a renowned surgeon and researcher specializing in breast cancer. In this conversation, we delve into her inspiring journey, groundbreaking research, and collaborative efforts that have led to significant advancements in breast cancer treatment. Robert Szulkin (RS):Jana, you’ve just published apaperon “Omitting Axillary Dissection in Breast […]

Read more

Planning Strategies for Externally Controlled Trials: Insights from ISPOR US 2024

External Control Arms (ECAs) provide comparative evidence when recruiting patients is difficult or unethical in randomized controlled trials. ECAs have significant potential to save resources and accelerate access to innovative treatment. In a previousblog, our experts took a deep dive into the concept of ECAs, their acceptable use cases, and the current regulatory guidance. Existing […]

Read more

How to Use a Living HTA Approach to Demonstrate Value in Real-Time (4)

Cytel

At Cytel, we cultivate a culture of continuous learning, exploration, and creativity, fostering personal growth and steering the search for ground-breaking solutions. Our team of specialized, multidisciplinary thought leaders collaborate with colleagues and clients, channeling both individual expertise and collective intelligence. Through our blog channel, Cytel Perspectives, we share valuable insights supporting every stage of your research—from the preclinical phase and trial design to market access and reimbursem*nt. Subscribe to our newsletter today to stay informed and inspired.

Read full employee bio

Claim your free 30-minute strategy session

Book a free, no-obligation strategy session with a Cytel expert to get advice on how to improve your drug’s probability of success and plot a clearer route to market.

How to Use a Living HTA Approach to Demonstrate Value in Real-Time (5)
How to Use a Living HTA Approach to Demonstrate Value in Real-Time (6)
How to Use a Living HTA Approach to Demonstrate Value in Real-Time (2024)

References

Top Articles
Latest Posts
Article information

Author: Moshe Kshlerin

Last Updated:

Views: 6489

Rating: 4.7 / 5 (77 voted)

Reviews: 84% of readers found this page helpful

Author information

Name: Moshe Kshlerin

Birthday: 1994-01-25

Address: Suite 609 315 Lupita Unions, Ronnieburgh, MI 62697

Phone: +2424755286529

Job: District Education Designer

Hobby: Yoga, Gunsmithing, Singing, 3D printing, Nordic skating, Soapmaking, Juggling

Introduction: My name is Moshe Kshlerin, I am a gleaming, attractive, outstanding, pleasant, delightful, outstanding, famous person who loves writing and wants to share my knowledge and understanding with you.